4DMedical (ASX:4DX) share price is climbing today on positive update

The 4DMedical (ASX:4DX) share price is soaring higher today after the company announced its first commercial scan in Australia.

The 4DMedical Ltd (ASX: 4DX) share price is soaring higher today as the company announced it completed its first commercial scan in Australia. In early trade, the 4DMedical share price shot up 6.1% to $2.24 but has since retreated to $2.19, up 3.79% at the time of writing.

A medical specialist holding a chest an xray or scan and giving a thumbs up, indicating good results for asx healthcare share price

Image source: Getty Images

What does 4DMedical do?

4DMedical is a Melbourne and Los Angeles-based software technology company commercialising its patented imaging platform, XV Technology.

This four-dimensional lung imaging technology utilises mathematic models and algorithms to convert X-ray scans into quantitative data. Physicians are then able to use this information to manage patients with respiratory and lung diseases.

The respiratory diagnostic sector represents a global market of more than US$31 billion per year.

What did 4DMedical announce?

In today's release, 4DMedical advised that it has successfully completed the first XV lung ventilation analysis software (XV LVAS) scan to a patient. Conducted in Victoria, Australia, the accomplishment occurred ahead of schedule. The delivery of the first XV LVAS arrived in September, 2020, six months earlier than planned.

As a result, 4DMedical will now move to roll-out its infrastructure from early 2021. The XV LVAS is expected to be installed within hospitals and imaging centres across the country, offering greater accessibility for all patients.

All facilities with XV LVAS will be able to offer 4DMedical's lung report for both inpatient and outpatient care. This in-turn will maximise the number of addressable patients for the company, effectively increasing revenue streams.

Management commentary

4DMedical CEO Andreas Fouras welcomed the progress, saying:

We're pleased to hit yet another milestone ahead of schedule and see our end-to-end SaaS clinical solution perform flawlessly in a real-world setting.

COVID-19 has seen traditional spirometry assessments shut down and our technology also provides an excellent alternative for patients who need regular and more detailed lung health assessments.

While this might be our first ever Australian patient report, we expect to scale up quickly and begin to make a real difference to lung health in Australia.

How has the 4DMedical share price performed?

Since debuting on the ASX in August at a price of 73 cents, the 4DMedical share price has gone from strength to strength. For investors who picked up shares before the listing, they would be sitting on returns of more than 206%.

The company's sharesreached an all-time high of $2.98 just 2 months ago, and are hovering 24% below.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »

Army man holding a drone while the army woman holds the remote control.
52-Week Lows

Can DroneShield shares rebound from fresh 52-week low, or is there more downside ahead?

Investors have fallen out of love with the counter-drone operator’s shares.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Frustrated man looking exhausted while sitting at his desk with his laptop and carrying his glasses in his hand.
ASX Share Market News

5 things to watch on the ASX 200 on Tuesday

It looks set to be a tough session for Aussie investors.

Read more »